CME

CME


Latest Episodes

Navigating Adjuvant ICI Treatment in Stage II Melanoma: A Patient Case Presentation
April 26, 2024

Host: Sapna Patel, MD This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropri

What Dermatologists & Surgeons Need To Know: Adjuvant Treatment for Resectable Stage III/IV Melanoma
April 26, 2024

Host: Jeffrey S. Weber, MD, PhD This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized

Case Consult: Adjuvant Therapy Following Localized Treatment for Stage III Melanoma
April 26, 2024

Host: Sapna Patel, MD This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropri

Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma
April 26, 2024

Host: Mario E. Lacouture, MD This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, a

Optimizing Resectable Melanoma Outcomes Through Multidisciplinary Care and Multimodal Treatment Strategies
April 26, 2024

Host: Mario E. Lacouture, MD Host: Sapna Patel, MD This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and s

Unlocking Synergy: Exploring the Interaction Between LAG-3 and Other Immune Checkpoints
April 26, 2024

Host: Hussein Tawbi, MD, PhD This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim to identify patients with metastatic melanoma who can benefit from LAG-3/PD-1 combinati

Future Directions: Targeting LAG-3 in Melanoma Treatment
April 26, 2024

Host: Hussein Tawbi, MD, PhD This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim to identify patients with metastatic melanoma who can benefit from LAG-3/PD-1 combinati

First-Line Treatment of Metastatic Melanoma After Adjuvant Anti-PD-1
April 26, 2024

Host: Allison Betof Warner, MD, PhD This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim to identify patients with metastatic melanoma who can benefit from LAG-3/PD-1 co

Experts on Call: Connecting Specialists and PCPs to Improve Patient-Centered Obesity Management
April 25, 2024

Host: Robert F. Kushner, MD Host: Donna Ryan, MD Host: Christopher D. Still, DO, FACN, FACP, FTOS Obesity experts review obesity management strategies and provide insight on best practices for implementation in a primary care setting.

Experts on the Ground: Data Updates on Emerging Therapies for IgAN
April 25, 2024

Host: Richard Lafayette, MD, FACP Expert Nephrologist Richard Lafayette, MD, FACP, gives an overview of top abstracts from Kidney Week 2023 and updates on emerging therapies for IgAN.